Endo International (ENDP) Shares Gap Down to $6.51

Endo International PLC (NASDAQ:ENDP) (TSE:ENL)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $5.62, but opened at $6.51. Endo International shares last traded at $6.72, with a volume of 94545 shares changing hands.

A number of equities analysts recently weighed in on ENDP shares. Zacks Investment Research raised Endo International from a “hold” rating to a “buy” rating and set a $11.00 price objective on the stock in a report on Thursday, January 17th. ValuEngine raised Endo International from a “sell” rating to a “hold” rating in a report on Monday, February 4th. Piper Jaffray Companies reissued a “hold” rating on shares of Endo International in a report on Friday, March 1st. Leerink Swann cut Endo International from an “outperform” rating to a “market perform” rating in a report on Tuesday, March 5th. Finally, Svb Leerink cut Endo International from an “outperform” rating to a “market perform” rating in a report on Tuesday, March 5th. Two analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have given a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $14.88.

The company has a market capitalization of $1.46 billion, a P/E ratio of 2.29 and a beta of 1.12.



Endo International (NASDAQ:ENDP) (TSE:ENL) last announced its quarterly earnings results on Thursday, May 9th. The company reported $0.53 EPS for the quarter, topping the Zacks’ consensus estimate of $0.42 by $0.11. The business had revenue of $720.00 million for the quarter, compared to analysts’ expectations of $692.31 million. Endo International had a negative return on equity of 199.18% and a negative net margin of 18.35%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.67 EPS. On average, equities research analysts forecast that Endo International PLC will post 2.2 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Oregon Public Employees Retirement Fund increased its stake in shares of Endo International by 1.8% during the first quarter. Oregon Public Employees Retirement Fund now owns 77,330 shares of the company’s stock valued at $621,000 after buying an additional 1,397 shares during the period. Piedmont Investment Advisors Inc. increased its stake in shares of Endo International by 3.5% during the fourth quarter. Piedmont Investment Advisors Inc. now owns 47,942 shares of the company’s stock valued at $350,000 after buying an additional 1,607 shares during the period. Mason Street Advisors LLC increased its stake in shares of Endo International by 3.4% during the first quarter. Mason Street Advisors LLC now owns 64,141 shares of the company’s stock valued at $515,000 after buying an additional 2,134 shares during the period. Neuburgh Advisers LLC increased its stake in shares of Endo International by 13.9% during the fourth quarter. Neuburgh Advisers LLC now owns 24,860 shares of the company’s stock valued at $181,000 after buying an additional 3,036 shares during the period. Finally, Comerica Bank increased its stake in shares of Endo International by 2.1% during the first quarter. Comerica Bank now owns 198,605 shares of the company’s stock valued at $1,650,000 after buying an additional 4,001 shares during the period. 94.93% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Endo International (ENDP) Shares Gap Down to $6.51” was originally reported by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://dakotafinancialnews.com/2019/05/16/endo-international-endp-shares-gap-down-to-6-51.html.

About Endo International (NASDAQ:ENDP)

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.

Further Reading: Return on Equity (ROE)

Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.